Atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer [ID1495]
Discontinued
Reference number: GID-TA10395
As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer.
Following on from information received from the company, please note that the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid- November 2019.